Company intelligence / Profile preview

Tel-Array Diagnostics

Vancouver, British Columbia, Canadatelarray.com ↗
Ownership
Private
Development stage
Preclinical
01

Overview

Tel-Array has developed the Spot Profiler, a portable in vitro diagnostic device using proprietary protein microarray technology for rapid (<15 min), multi-marker point-of-care testing. The company is preparing to commercialize its benchtop system targeting emergency departments and ambulatory care settings[2][4].

Therapeutic areas
Other
Modalities
DeviceImmunoassay-based diagnosticProtein microarray
Industry
Protein Biomarker Diagnostics
02

Partnerships

None publicly disclosed

Beyond the preview

Go deeper on Tel-Array Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tel-Array Diagnostics.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call